hers reviews semaglutide Hims & says its weight-loss business can grow as US market changes Doctor Reacts: Hims & Hers

In addition, no significant decline in body weight was observed and the groups did not differ with respect to the amount of body weight gained [F (1, 18) = 0.6165, P = 0.4426]

doi:10.1136/bmj.q1448 Whitley HP, Trujillo JM, Neumiller JJ

Regulatory Context: The telehealth GLP-1 and compounding space has experienced rapid growth and regulatory attention

These may include weight, fluid intake, or a daily nausea score, which will help you decide whether to hold, slow, or continue the ramp

Patients with low risk may proceed with standard interventions and periodic monitoring, for instance quarterly app-based check-ins or brief clinical interviews